Genentech

RITUXAN HYCELA

Manufacturer:

Genentech

Rituxan Hycela HCPCS:

J9311

HCPCS Code Descriptor:

Injection, rituximab 10 mg and hyaluronidase

Category:

J Code

Rituxan Hycela NDCs:

50242-0108-01, 50242-0109-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Subcutaneous

Rituxan Hycela CPT Codes:

Potential CPT administration codes for Rituxan Hycela can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Rituxan Hycela:

RITUXAN HYCELA is an Oncology drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J9311 is aligned to the drug RITUXAN HYCELA.

ACCESS PRICING AND MORE BY REGISTERING

J9311 Added Date:

January 1, 2019

J9311 Effective Date:

January 1, 2019

J9311 Termination Date:

HCPCS Active

Rituxan Hycela billing and coding information can be found through Genentech at the link below:
Rituxan Hycela patient assistance information can be found through Genentech at the URL: https://www.genentech-access.com/hcp/brands/rituxan-hycela/find-patient-assistance.html
RITUXAN HYCELA prescribing information can be found at the link below:
Information regarding RITUXAN HYCELA’s side effects can be found at MedlinePlus